Greg Downey has over 25 years of helping promising start-up, growth and public companies increase sales and market dominance in the United States and abroad. His operational experience covers areas such as business development, product commercialization, branding, digital marketing, sales, ecommerce, distribution, and building strategic industry and investor relationships. His personal efforts have generated over $100M in sales, contributed to 2 exits, 1 acquisition and an IPO. Greg has also helped lead over $70M in private financings for early-stage, growth companies, and real estate projects. He has also assisted in bringing innovative technologies to the Veterans Health Administration, a network of over 170 medical centers and 9 million enrolled patients.
Greg began his career by helping launch a minimally invasive surgical division of Johnson & Johnson that quickly became the global leader in women’s health and urology. He then went on to serve in executive sales, marketing and business development capacities for a venture backed ecommerce company, Medibuy, that was acquired by Premier. After the sale, he went on to serve as Vice President of Sales and Marketing for NoInk Communications, a mobile salesforce software company spun out of Rose-Hulman Institute of Technology. At NoInk, Greg developed and implemented a strategy that resulted in the company being the leader in the medical device industry and was responsible for over 90% of revenue before the company was acquired. He later went on to assist an international investment firm in bringing an innovative AI middleware company out of Sweden, Appear Networks, into U.S. Homeland Security in New York City, and eventually into healthcare through partnerships with Cisco, Intel, and Siemens.
Greg later invested then joined the founding team of OrthoPediatrics, currently the largest international orthopedics company solely focused on providing innovative solutions for children with musculoskeletal conditions. As a board member and Vice President of Marketing and Business Development, he developed the company’s branding strategy, recruited top surgeons, led multiple capital raises resulting in $19M in private capital, managed investor relations, and technology transfer with notable institutions like the Cleveland Clinic and the University of California San Francisco. OrthoPediatrics became a publicly traded company in October 2017 (NASDAQ: KIDS) and is regarded as one of the top 10 performing IPOs of 2017.
In 2010, Greg co-founded Purim Ventures, a venture studio focused on providing strategic advisory and business development services to disruptive companies in medical device, biologics, regenerative medicine, cloud computing, blockchain, consumer products, nutraceuticals, real estate, and health and wellness.
Greg serves as an advisor and on the board of several non-profit organizations and privately held companies, including SKN BioPharma, PolyXLabs, Genesis New Ventures, the University of South Florida’s CONNECT Research & Innovation Center, and as a senior advisor to one of the most successful Service-Disabled Veteran Owned Small Businesses (SDVOSB) serving the VA and the Department of Defense. He also works with family offices and private equity funds in the areas of due diligence, subject matter expertise, and deal sourcing.